Friday 18 November 2016

NYU Dentistry awarded $1.9 million from NIDDK for osteoporosis drug research and development

(New York University) The federally funded grant will support bench research aimed at understanding how the protein hormone, parathyroid hormone-a related protein-and a drug analog that mimics the protein called abaloparatide, interact in the surface of a cell in bone and affect bone formation and breakdown.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2g5lSIw

No comments:

Post a Comment